About Tissue Genesis
Tissue Genesis is a company based in Honolulu (United States) founded in 2001 was acquired by Orgenesis in October 2020.. Tissue Genesis has raised $22.14 million across 12 funding rounds from investors including Orgenesis and Military Health. The company has 5 employees as of December 31, 2022. Tissue Genesis offers products and services including Icellator 2 and Cell Icellation Kit. Tissue Genesis operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and ViaCyte, among others.
- Headquarter Honolulu, United States
- Employees 5 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tissue Genesis, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tissue Genesis
Tissue Genesis offers a comprehensive portfolio of products and services, including Icellator 2 and Cell Icellation Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated system for extracting stem cells from adipose tissue quickly.
Sterile kit for efficient stem cell isolation and processing.
Funding Insights of Tissue Genesis
Tissue Genesis has successfully raised a total of $22.14M across 12 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series A — $500,000
-
First Round
First Round
(30 Jan 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Series A - Tissue Genesis | Valuation |
investors |
|
| Jan, 2012 | Amount | Series A - Tissue Genesis | Valuation |
investors |
|
| Jul, 2011 | Amount | Series A - Tissue Genesis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tissue Genesis
Tissue Genesis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Orgenesis and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location | |
|
Cell and gene therapies for multiple disorders are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tissue Genesis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tissue Genesis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tissue Genesis Comparisons
Competitors of Tissue Genesis
Tissue Genesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and ViaCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Cell therapy for diabetes is developed from stem cells.
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tissue Genesis
Frequently Asked Questions about Tissue Genesis
When was Tissue Genesis founded?
Tissue Genesis was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Where is Tissue Genesis located?
Tissue Genesis is headquartered in Honolulu, United States. It is registered at Honolulu, Hawaii, United States.
Is Tissue Genesis a funded company?
Tissue Genesis is a funded company, having raised a total of $22.14M across 12 funding rounds to date. The company's 1st funding round was a Series A of $5.63M, raised on Jan 30, 2009.
How many employees does Tissue Genesis have?
As of Dec 31, 2022, the latest employee count at Tissue Genesis is 5.
What does Tissue Genesis do?
Tissue Genesis develops stem cell therapeutics for tissue healing. Its proprietary platform technology Icellator Cell Isolation System isolates stem cells from the patients adipose tissue. In addition, the company also develops Adipase, designed to optimize the isolation process of the Icellator. Tissue Genesis is currently conducting clinical trials for the use of stem cells in peripheral vascular disease and erectile dysfunction.
Who are the top competitors of Tissue Genesis?
Tissue Genesis's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.
What products or services does Tissue Genesis offer?
Tissue Genesis offers Icellator 2 and Cell Icellation Kit.
Who are Tissue Genesis's investors?
Tissue Genesis has 2 investors. Key investors include Orgenesis, and Military Health.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.